open access

Vol 10, No 3 (2005)
Original Paper
Published online: 2005-01-01
Submitted: 2005-01-06
Get Citation

500 kHz hyperthermia assisted HDR brachytherapy in the treatment of recurrent cervical and endometrial cancer in previously irradiated fields

Norbert Piotrkowicz, Jan Zieliński, Joanna Jońska, Piotr Dębicki
DOI: 10.1016/S1507-1367(05)71085-3
·
Rep Pract Oncol Radiother 2005;10(3):131-134.

open access

Vol 10, No 3 (2005)
Original Paper
Published online: 2005-01-01
Submitted: 2005-01-06

Abstract

Background

The biological effectiveness of elevated temperature (hyperthermia) on cancer cells is a well documented issue. Nevertheless, it is still not widely used in clinical practice, mainly due to technical difficulties. The main limiting factor is the protection of healthy tissue during the hyperthermia procedure. Hyperthermia, used as an adjuvant treatment with brachytherapy, provides the possibility of lowering total radiation doses, without reducing biological effects.

Aim

The aim of this work was to present the advantages of using 500 kHz hyperthermia in HDR brachytherapy of cervical & endometrial cancer.

Materials/Methods

Hyperthermia procedures were performed in 8 endometrial cancer patients and 2 cervical cancer patients with early recurrent local disease in previously irradiated areas. One or two interstitial hyperthermia procedures were performed using rigid metal needles, both for brachytherapy and temperature elevation. The total radiation dose was 30 Gy, delivered in 3 or 6 Gy per fraction. In the case of 3 Gy per fraction, a scheme of two fractions per day, separated by at least 8 hours, was used. The total treatment time ranged from 5 to 14 days. Hyperthermia was performed concurrently with brachytherapy.

Results

During the treatment, no acute reactions were observed. In each case, tumour regression over 50% was noted. During the 3 to 14 month follow-up period, complete vaginal tumour regression was seen in 8 of 10 cases.

Conclusions

500 kHz hyperthermia assisted interstitial brachytherapy can be regarded as effective and safe procedure, especially when applied as secondary (salvage) treatment. More cases and longer observation time are needed to make definite conclusions.

Abstract

Background

The biological effectiveness of elevated temperature (hyperthermia) on cancer cells is a well documented issue. Nevertheless, it is still not widely used in clinical practice, mainly due to technical difficulties. The main limiting factor is the protection of healthy tissue during the hyperthermia procedure. Hyperthermia, used as an adjuvant treatment with brachytherapy, provides the possibility of lowering total radiation doses, without reducing biological effects.

Aim

The aim of this work was to present the advantages of using 500 kHz hyperthermia in HDR brachytherapy of cervical & endometrial cancer.

Materials/Methods

Hyperthermia procedures were performed in 8 endometrial cancer patients and 2 cervical cancer patients with early recurrent local disease in previously irradiated areas. One or two interstitial hyperthermia procedures were performed using rigid metal needles, both for brachytherapy and temperature elevation. The total radiation dose was 30 Gy, delivered in 3 or 6 Gy per fraction. In the case of 3 Gy per fraction, a scheme of two fractions per day, separated by at least 8 hours, was used. The total treatment time ranged from 5 to 14 days. Hyperthermia was performed concurrently with brachytherapy.

Results

During the treatment, no acute reactions were observed. In each case, tumour regression over 50% was noted. During the 3 to 14 month follow-up period, complete vaginal tumour regression was seen in 8 of 10 cases.

Conclusions

500 kHz hyperthermia assisted interstitial brachytherapy can be regarded as effective and safe procedure, especially when applied as secondary (salvage) treatment. More cases and longer observation time are needed to make definite conclusions.

Get Citation

Keywords

cervical cancer; endometrial cancer; brachytherapy; secondary radiotherapy

About this article
Title

500 kHz hyperthermia assisted HDR brachytherapy in the treatment of recurrent cervical and endometrial cancer in previously irradiated fields

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 10, No 3 (2005)

Pages

131-134

Published online

2005-01-01

DOI

10.1016/S1507-1367(05)71085-3

Bibliographic record

Rep Pract Oncol Radiother 2005;10(3):131-134.

Keywords

cervical cancer
endometrial cancer
brachytherapy
secondary radiotherapy

Authors

Norbert Piotrkowicz
Jan Zieliński
Joanna Jońska
Piotr Dębicki

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl